MAC 1/LFA 1/P150 95 AND PMN LEUKOCYTE FUNCTION
MAC 1/LFA 1/P150 95 和 PMN 白细胞功能
基本信息
- 批准号:6390269
- 负责人:
- 金额:$ 34.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-04-01 至 2003-03-31
- 项目状态:已结题
- 来源:
- 关键词:CD antigens antibody receptor biological signal transduction cell adhesion cell cell interaction cell migration gene mutation genetically modified animals hydrogen peroxide inflammation integrins laboratory mouse leukocyte activation /transformation leukocyte adhesion molecules leukocytes neutrophil protein structure function
项目摘要
DESCRIPTION (Adapted from Investigator's Abstract): Inflammation plays an
important role in cardiovascular disease, and the CD11/CD18 integrins are
attractive targets for the development of new therapeutic agents. Complete
inhibition of CD18, the common beta chain of the leukocyte integrins,
profoundly reduces emigration of neutrophils (PMN) at sites of inflammation and
leads to a severe immunodeficiency syndrome (leukocyte adhesion deficiency type
I, LAD I). Although the genetic disorder LAD I has provided great insight into
the functional significance of the CD18 family, the relative contributions of
each of the CD11 integrins in the phenotypic abnormalities seen in LAD I remain
unclear. Selective inhibition of specific CD11 integrins could potentially have
therapeutic benefit in specific inflammatory conditions without broad
impairment of host defense. In an effort to evaluate the function of each CD11
integrin, mice will be generated for use in two general experimental paradigms:
First, to assess the functional consequences of the loss of a single CD11
integrin, and second, to assess the functions retained when a single CD11
integrin is present. The specific aims are: 1. Develop mice with specific
deficiencies in each of the CD11 integrins and important combined mutations by
targeted homologous recombination in embryonic stem cells. Mice have already
been developed that are deficient in CD11a, CD11b, and CD11c. In order to
better define the role of CD11 integrins in PMN function, the investigator
proposes to make the double knockouts of CD11a + CD11b, CD11b + CD11c, and
CD11a + CD11c, in which only a single CD11 chain is present on murine PMN,
which lack CD11d. 2. Characterize the phenotypic changes due to selective
deficiencies of the CD11 integrins with respect to neutrophil function. A
combination of in vitro and in vivo studies will provide novel information on
the functions of individual CD11 integrins in migration, adhesion,
degranulation, hydrogen peroxide production, and cellular signaling, including
interactions with the Fc receptors. 3. Characterize the contribution of each
CD11 integrin on the host response to common bacterial and fungal pathogens in
vitro and in vivo.
描述(改编自研究者摘要):炎症起着重要的作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTIE Mitchell BALLANTYNE其他文献
CHRISTIE Mitchell BALLANTYNE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTIE Mitchell BALLANTYNE', 18)}}的其他基金
Clonal hematopoiesis in humans: determinants of development and progression
人类克隆造血:发育和进展的决定因素
- 批准号:
10202719 - 财政年份:2019
- 资助金额:
$ 34.55万 - 项目类别:
Clonal hematopoiesis in humans: determinants of development and progression
人类克隆造血:发育和进展的决定因素
- 批准号:
9980999 - 财政年份:2019
- 资助金额:
$ 34.55万 - 项目类别:
Clonal hematopoiesis in humans: determinants of development and progression
人类克隆造血:发育和进展的决定因素
- 批准号:
10448235 - 财政年份:2019
- 资助金额:
$ 34.55万 - 项目类别:
Profiling Cardiovascular Events and Biomarkers in the Very Old to Improve Personalized Approaches for the Prevention of Cardiac and Vascular Disease
分析老年人的心血管事件和生物标志物,以改进预防心脏和血管疾病的个性化方法
- 批准号:
9277554 - 财政年份:2016
- 资助金额:
$ 34.55万 - 项目类别:
EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULA
脂质修饰对血管内术后周围动脉疾病的影响
- 批准号:
8356766 - 财政年份:2010
- 资助金额:
$ 34.55万 - 项目类别:
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity
饮食引起的肥胖中的 T 细胞、巨噬细胞、趋化因子和脂肪病
- 批准号:
8452140 - 财政年份:2009
- 资助金额:
$ 34.55万 - 项目类别:
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity
饮食引起的肥胖中的 T 细胞、巨噬细胞、趋化因子和脂肪病
- 批准号:
7825438 - 财政年份:2009
- 资助金额:
$ 34.55万 - 项目类别:
Genetics and Personalized Medicine: From Population Studies to Clinical Therapy
遗传学和个性化医疗:从人口研究到临床治疗
- 批准号:
7936114 - 财政年份:2009
- 资助金额:
$ 34.55万 - 项目类别:
T Cells, Macrophages, Chemokines, and Adiposopathy in Diet-Induced Obesity
饮食引起的肥胖中的 T 细胞、巨噬细胞、趋化因子和脂肪病
- 批准号:
8249901 - 财政年份:2009
- 资助金额:
$ 34.55万 - 项目类别:
EFFECT OF LIPID MODIFICATION ON PERIPHERAL ARTERIAL DISEASE AFTER ENDOVASCULA
脂质修饰对血管内术后周围动脉疾病的影响
- 批准号:
8166761 - 财政年份:2009
- 资助金额:
$ 34.55万 - 项目类别:
相似海外基金
Study on the mechanism of prolonged half-life of blood IgY by unique antibody receptor and its application to immune enhancement in birds
独特抗体受体延长血液IgY半衰期的机制研究及其在禽类免疫增强中的应用
- 批准号:
23H02361 - 财政年份:2023
- 资助金额:
$ 34.55万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : GNT1124162 - 财政年份:2017
- 资助金额:
$ 34.55万 - 项目类别:
Early Career Fellowships
Innate immune functions of the intracellular antibody receptor TRIM21
细胞内抗体受体 TRIM21 的先天免疫功能
- 批准号:
nhmrc : 1124162 - 财政年份:2017
- 资助金额:
$ 34.55万 - 项目类别:
Early Career Fellowships
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9300976 - 财政年份:2015
- 资助金额:
$ 34.55万 - 项目类别:
Mechanism and engineering of IgG-based monoclonal antibody/receptor interactions
基于 IgG 的单克隆抗体/受体相互作用的机制和工程
- 批准号:
9920805 - 财政年份:2015
- 资助金额:
$ 34.55万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8900121 - 财政年份:2012
- 资助金额:
$ 34.55万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8225814 - 财政年份:2012
- 资助金额:
$ 34.55万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8699511 - 财政年份:2012
- 资助金额:
$ 34.55万 - 项目类别:
Augmenting Chimeric Antibody Receptor Directed T cell Therapy for Cancer
增强嵌合抗体受体定向 T 细胞治疗癌症
- 批准号:
8525355 - 财政年份:2012
- 资助金额:
$ 34.55万 - 项目类别:
Small Grants for Exploratory Research: Separation of Cells and Biological Macromolecules by Antibody Receptor Coated Magnetic Vesicles and Ferritin Conjugates
探索性研究小额资助:通过抗体受体包被的磁囊和铁蛋白缀合物分离细胞和生物大分子
- 批准号:
9115537 - 财政年份:1991
- 资助金额:
$ 34.55万 - 项目类别:
Standard Grant














{{item.name}}会员




